Compare SGI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGI | PEN |
|---|---|---|
| Founded | 1846 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.6B |
| IPO Year | 2003 | 2015 |
| Metric | SGI | PEN |
|---|---|---|
| Price | $65.01 | $327.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 16 |
| Target Price | $97.88 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 2.8M | 319.6K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | 1.01 | ★ 1.70 |
| Revenue | ★ $2,754,400,000.00 | $1,403,665,000.00 |
| Revenue This Year | $7.30 | $14.34 |
| Revenue Next Year | $4.99 | $13.71 |
| P/E Ratio | ★ $65.41 | $192.36 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $60.39 | $221.26 |
| 52 Week High | $98.56 | $362.41 |
| Indicator | SGI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 72.30 |
| Support Level | $63.52 | $326.58 |
| Resistance Level | $71.88 | $329.67 |
| Average True Range (ATR) | 2.27 | 2.12 |
| MACD | -0.07 | 0.48 |
| Stochastic Oscillator | 24.93 | 90.47 |
Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses Mattress Firm, Tempur Sealy North America and Tempur Sealy International. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.